Purchase Order 36C25624P1662

Award Date 9/5/24
Potential Completion Date 10/5/24
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70119, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the provision of Novocure Inc.'s Optune Plus Transducer Therapy System to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract. The contract, which does not utilize any set-aside designations, was awarded on March 27, 2024, with a period of performance through June 26, 2024....
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducers, device rentals, and related support services. The $16,582.91 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 and runs through October...
This federal contract award is for the provision of Novocure Inc.'s Optune medical device and associated products and services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of cancer therapy medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order. The award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus electronic stimulation cancer treatment devices and associated services. The contract is a firm-fixed-price purchase order with a performance period extending to February 7, 2025. Novocure delivers its proprietary...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is a delivery order placed under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This FSS contract, awarded in November 2022, provides a streamlined procurement vehicle for the VA to obtain...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's existing 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, to provide its Optune Transducer Plus products and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $49,748.73, is a delivery order (contract number 36F79723D0016) issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA. This multiple-award FSS contract, with a $28.85 million...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) that Novocure holds with...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...

This federal contract award is for the procurement of prosthetics from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a firm fixed price of $49,748.73 and a performance period ending on October 5, 2024. This order was issued under Novocure's existing Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 with a ceiling value of $28.85 million and runs through October 31, 2027. The contract does not utilize any set-aside designations. The award enables the VA to continue offering Novocure's proprietary Optune Tumor Treating Fields (TTFields) therapy to veteran patients diagnosed with glioblastoma and other solid tumor cancers, consistent with the VA's mission of expanding access to innovative cancer treatments for the veteran population.

Generated 9/6/24, 9:19 AM